And NAD+-Dependent Formate Dehydrogenase from Cupriavidus Necator
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Harnessing Escherichia Coli for Bio-Based Production of Formate
bioRxiv preprint doi: https://doi.org/10.1101/2021.01.06.425572; this version posted January 6, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Harnessing Escherichia coli for bio‐based production of formate under pressurized H2 and CO2 gases. Magali Roger1,2, Tom C. Reed2 and Frank Sargent2* 1 Aix Marseille University, CNRS, Bioenergetics and Protein Engineering (BIP UMR7281), 31 Chemin Joseph Aiguier, CS70071, 13042 Marseille Cedex 09, France. 2 School of Natural and Environmental Sciences, Newcastle University, Newcastle upon Tyne, NE1 7RU, England, UK *For Correspondence: Prof Frank Sargent FRSE, Division of Plant & Microbial Biology, School of Natural & Environmental Sciences, Newcastle University, Devonshire Building, Kensington Terrace, Newcastle upon Tyne NE2 4BF, England, United Kingdom. T: +44 191 20 85138. E: [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.01.06.425572; this version posted January 6, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. ABSRACT Escherichia coli is gram‐negative bacterium that is a workhorse of the biotechnology industry. The organism has a flexible metabolism and can perform a mixed‐acid fermentation under anaerobic conditions. Under these conditions E. coli synthesises a formate hydrogenlyase isoenzyme (FHL‐1) that can generate molecular hydrogen and carbon dioxide from formic acid. -
Progressive Encephalopathy and Central Hypoventilation Related to Homozygosity of NDUFV1 Nuclear Gene, a Rare Mitochondrial Disease
Avens Publishing Group Inviting Innovations Open Access Case Report J Pediatr Child Care August 2019 Volume:5, Issue:1 © All rights are reserved by AL-Buali MJ, et al. AvensJournal Publishing of Group Inviting Innovations Progressive Encephalopathy Pediatrics & and Central Hypoventilation Child Care AL-Buali MJ*, Al Ramadhan S, Al Buali H, Al-Faraj J and Related to Homozygosity of Al Mohanna M Pediatric Department , Maternity Children Hospital , Saudi Arabia *Address for Correspondence: NDUFV1 Nuclear Gene, a Rare Al-buali MJ, Pediatric Consultant and Consultant of Medical Genetics, Deputy Chairman of Medical Genetic Unite, Pediatrics Department , Maternity Children Hospital, Al-hassa, Hofuf city, Mitochondrial Disease Saudi Arabia; E-mail: [email protected] Submission: 15 July 2019 Accepted: 5 August 2019 Keywords: Progressive encephalopathy; Central hypoventilation; Published: 9 August 2019 Nuclear mitochondrial disease; NDUFV1 gene Copyright: © 2019 AL-Buali MJ, et al. This is an open access article distributed under the Creative Commons Attribution License, which Abstract permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Background: Mitochondrial diseases are a group of disorders caused by dysfunctional organelles that generate energy for our body. Mitochondria small double-membrane organelles found in of the most common groups of genetic diseases with a minimum every cell of the human body except red blood cells. Mitochondrial diseases are sometimes caused by mutations in the mitochondrial DNA prevalence of greater than 1 in 5000 in adults. Mitochondrial diseases that affect mitochondrial function. Other mitochondrial diseases are can be present at birth but can be manifested also at any age [2]. -
Sulfite Dehydrogenases in Organotrophic Bacteria : Enzymes
Sulfite dehydrogenases in organotrophic bacteria: enzymes, genes and regulation. Dissertation zur Erlangung des akademischen Grades des Doktors der Naturwissenschaften (Dr. rer. nat.) an der Universität Konstanz Fachbereich Biologie vorgelegt von Sabine Lehmann Tag der mündlichen Prüfung: 10. April 2013 1. Referent: Prof. Dr. Bernhard Schink 2. Referent: Prof. Dr. Andrew W. B. Johnston So eine Arbeit wird eigentlich nie fertig, man muss sie für fertig erklären, wenn man nach Zeit und Umständen das möglichste getan hat. (Johann Wolfgang von Goethe, Italienische Reise, 1787) DANKSAGUNG An dieser Stelle möchte ich mich herzlich bei folgenden Personen bedanken: . Prof. Dr. Alasdair M. Cook (Universität Konstanz, Deutschland), der mir dieses Thema und seine Laboratorien zur Verfügung stellte, . Prof. Dr. Bernhard Schink (Universität Konstanz, Deutschland), für seine spontane und engagierte Übernahme der Betreuung, . Prof. Dr. Andrew W. B. Johnston (University of East Anglia, UK), für seine herzliche und bereitwillige Aufnahme in seiner Arbeitsgruppe, seiner engagierten Unter- stützung, sowie für die Übernahme des Koreferates, . Prof. Dr. Frithjof C. Küpper (University of Aberdeen, UK), für seine große Hilfsbereitschaft bei der vorliegenden Arbeit und geplanter Manuskripte, als auch für die mentale Unterstützung während der letzten Jahre! Desweiteren möchte ich herzlichst Dr. David Schleheck für die Übernahme des Koreferates der mündlichen Prüfung sowie Prof. Dr. Alexander Bürkle, für die Übernahme des Prüfungsvorsitzes sowie für seine vielen hilfreichen Ratschläge danken! Ein herzliches Dankeschön geht an alle beteiligten Arbeitsgruppen der Universität Konstanz, der UEA und des SAMS, ganz besonders möchte ich dabei folgenden Personen danken: . Dr. David Schleheck und Karin Denger, für die kritische Durchsicht dieser Arbeit, der durch und durch sehr engagierten Hilfsbereitschaft bei Problemen, den zahlreichen wissenschaftlichen Diskussionen und für die aufbauenden Worte, . -
Inactivation Mechanisms of Alternative Food Processes on Escherichia Coli O157:H7
INACTIVATION MECHANISMS OF ALTERNATIVE FOOD PROCESSES ON ESCHERICHIA COLI O157:H7 DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Aaron S. Malone, M.S. ***** The Ohio State University 2009 Dissertation Committee: Approved by Professor Ahmed E. Yousef, Adviser Professor Polly D. Courtney ___________________________________ Professor Tina M. Henkin Adviser Food Science and Nutrition Professor Robert Munson ABSTRACT Application of high pressure (HP) in food processing results in a high quality and safe product with minimal impact on its nutritional and organoleptic attributes. This novel technology is currently being utilized within the food industry and much research is being conducted to optimize the technology while confirming its efficacy. Escherichia coli O157:H7 is a well studied foodborne pathogen capable of causing diarrhea, hemorrhagic colitis, and hemolytic uremic syndrome. The importance of eliminating E. coli O157:H7 from food systems, especially considering its high degree of virulence and resistance to environmental stresses, substantiates the need to understand the physiological resistance of this foodborne pathogen to emerging food preservation methods. The purpose of this study is to elucidate the physiological mechanisms of processing resistance of E. coli O157:H7. Therefore, resistance of E. coli to HP and other alternative food processing technologies, such as pulsed electric field, gamma radiation, ultraviolet radiation, antibiotics, and combination treatments involving food- grade additives, were studied. Inactivation mechanisms were investigated using molecular biology techniques including DNA microarrays and knockout mutants, and quantitative viability assessment methods. The results of this research highlighted the importance of one of the most speculated concepts in microbial inactivation mechanisms, the disruption of intracellular ii redox homeostasis. -
Metabolic Engineering of Cupriavidus Necator for Heterotrophic and Autotrophic Alka(E)Ne Production Lucie Crepin, Eric Lombard, Stéphane Guillouet
Metabolic engineering of Cupriavidus necator for heterotrophic and autotrophic alka(e)ne production Lucie Crepin, Eric Lombard, Stéphane Guillouet To cite this version: Lucie Crepin, Eric Lombard, Stéphane Guillouet. Metabolic engineering of Cupriavidus necator for heterotrophic and autotrophic alka(e)ne production. Metabolic Engineering, Elsevier, 2016, 37, pp.92- 101. 10.1016/j.ymben.2016.05.002. hal-01886395 HAL Id: hal-01886395 https://hal.archives-ouvertes.fr/hal-01886395 Submitted on 14 Apr 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Metabolic Engineering 37 (2016) 92–101 Contents lists available at ScienceDirect Metabolic Engineering journal homepage: www.elsevier.com/locate/ymben Metabolic engineering of Cupriavidus necator for heterotrophic and autotrophic alka(e)ne production Lucie Crépin, Eric Lombard, Stéphane E Guillouet n LISBP, Université de Toulouse, CNRS, INRA, INSA, 135 Avenue de Rangueil, 31077 Toulouse CEDEX 04, France article info abstract Article history: Alkanes of defined carbon chain lengths can serve as alternatives to petroleum-based fuels. Recently, Received 18 March 2016 microbial pathways of alkane biosynthesis have been identified and enabled the production of alkanes in Received in revised form non-native producing microorganisms using metabolic engineering strategies. -
Scope of the Thesis
Unraveling predatory-prey interactions between bacteria Dissertation To Fulfill the Requirements for the Degree of „Doctor rerum naturalium“ (Dr. rer. nat.) Submitted to the Council of the Faculty of Biology and Pharmacy of the Friedrich Schiller University Jena By Ivana Seccareccia (M.Sc. in Biology) born on 8th April 1986 in Rijeka, Croatia Die Forschungsarbeit im Rahmen dieser Dissertation wurde am Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e.V. – Hans-Knöll–Institut in der Nachwuchsgruppe Sekundärmetabolismus räuberischer Bakterien unter der Betreuung von Dr. habil. Markus Nett von Oktober 2011 bis Oktober 2015 in Jena durchgeführt. Gutachter: ……………………………………………. ………………………………………….… ……………………………………………. Tag der öffentlichen Verteidigung: We make our world significant by the courage of our questions and by the depth of our answers. Carl Sagan Table of Contents 1 Introduction ......................................................................................................................... 6 1.1 Predation in the microbial community ........................................................................... 6 1.2 Bacterial predators .......................................................................................................... 7 1.3 Phases of predation ......................................................................................................... 8 1.3.1 Seeking prey ......................................................................................................... 9 1.3.2 Prey recognition -
Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase -
Supplementary Material Title Comparative Proteomic Analysis Of
Supplementary Material Title Comparative proteomic analysis of wild-type Physcomitrella patens and an OPDA-deficient Physcomitrella patens mutant with disrupted PpAOS1 and PpAOS2 genes after wounding Authors Weifeng Luoa, Setsuko Komatsub, Tatsuya Abea, Hideyuki Matsuuraa, and Kosaku Takahashia,c* Affiliations aResearch Faculty of Agriculture, Hokkaido University, Sapporo 606-8589, Japan bDepartment of Environmental and Food Sciences, Faculty of Environmental and Information Sciences, Fukui University of Technology, 3-6-1 Gakuen, Fukui 910-8505, Japan cDepartment of Nutritional Science, Faculty of Applied BioScience, Tokyo University of Agriculture, Tokyo 165-8502, Japan. *To whom correspondence should be addressed: Tel.: +81-3-5477-2679; E-mail: [email protected]. Supplementary Fig. S1. Fig. S1. Disruption of PpAOS1 and PpAOS2 genes in P. p a te ns . A, Genomic structures of PpAOS1 and PpAOS2 in the wild-type and targeted PpAOS1 and PpAOS2 knock-out mutants (A5, A19, and A22). The npt II and aph IV expression cassettes were inserted in A5, A19, and A22 strains. B, Genomic PCR data of wild-type, and A5, A19 and A22 strains. P. patens genomic DNA was isolated from protonemata by the CTAB method (Nishiyama et al., Ref. 32). PCR was performed in 50 µL of a reaction mixture containing 1 µL of genomic DNA solution, 1.5 µL of each primer (5 µM), 25 µL of KOD One PCR Master Mix (Toyobo, Japan), and 21 µL of Milli-Q water. PCR was conducted with the following conditions: 30 cycles of 98°C for 10 s, 58°C for 5 s, and 68°C for 15 s. -
The Microbiota-Produced N-Formyl Peptide Fmlf Promotes Obesity-Induced Glucose
Page 1 of 230 Diabetes Title: The microbiota-produced N-formyl peptide fMLF promotes obesity-induced glucose intolerance Joshua Wollam1, Matthew Riopel1, Yong-Jiang Xu1,2, Andrew M. F. Johnson1, Jachelle M. Ofrecio1, Wei Ying1, Dalila El Ouarrat1, Luisa S. Chan3, Andrew W. Han3, Nadir A. Mahmood3, Caitlin N. Ryan3, Yun Sok Lee1, Jeramie D. Watrous1,2, Mahendra D. Chordia4, Dongfeng Pan4, Mohit Jain1,2, Jerrold M. Olefsky1 * Affiliations: 1 Division of Endocrinology & Metabolism, Department of Medicine, University of California, San Diego, La Jolla, California, USA. 2 Department of Pharmacology, University of California, San Diego, La Jolla, California, USA. 3 Second Genome, Inc., South San Francisco, California, USA. 4 Department of Radiology and Medical Imaging, University of Virginia, Charlottesville, VA, USA. * Correspondence to: 858-534-2230, [email protected] Word Count: 4749 Figures: 6 Supplemental Figures: 11 Supplemental Tables: 5 1 Diabetes Publish Ahead of Print, published online April 22, 2019 Diabetes Page 2 of 230 ABSTRACT The composition of the gastrointestinal (GI) microbiota and associated metabolites changes dramatically with diet and the development of obesity. Although many correlations have been described, specific mechanistic links between these changes and glucose homeostasis remain to be defined. Here we show that blood and intestinal levels of the microbiota-produced N-formyl peptide, formyl-methionyl-leucyl-phenylalanine (fMLF), are elevated in high fat diet (HFD)- induced obese mice. Genetic or pharmacological inhibition of the N-formyl peptide receptor Fpr1 leads to increased insulin levels and improved glucose tolerance, dependent upon glucagon- like peptide-1 (GLP-1). Obese Fpr1-knockout (Fpr1-KO) mice also display an altered microbiome, exemplifying the dynamic relationship between host metabolism and microbiota. -
The DMSO Reductase Family of Microbial Molybdenum Enzymes Alastair G
SHOWCASE ON RESEARCH The DMSO Reductase Family of Microbial Molybdenum Enzymes Alastair G. McEwan and Ulrike Kappler Centre for Metals in Biology, School of Molecular and Microbial Sciences, University of Queensland, QLD 4072 Molybdenum is the only element in the second row of led to a division of the oxotransferases into the sulfite transition metals which has a defined role in biology. It dehydrogenase and the dimethylsulfoxide (DMSO) exhibits redox states of (VI), (V) and (IV) within a reductase families (Fig. 1) (4). The Mo hydroxylases biologically-relevant range of redox potentials and is and oxotransferases can act either as dehydrogenases capable of catalysing both oxygen atom transfer and or reductases in catalysis. This reaction can be proton/electron transfer. Apart from nitrogenase, all summarised by the general scheme: + - enzymes containing molybdenum have an active site X + H2O D X=O + 2H + 2e composed of a molybdenum ion coordinated by one or During this process the Mo ion cycles between the two ene-dithiolate (dithiolene) groups that arise from (IV) and (VI) oxidation states with electrons being an unusual organic moiety known as the pterin transferred to or from an electron transfer partner or molybdenum cofactor or pyranopterin (1,2). The substrate. Experiments with xanthine dehydrogenase mononuclear molybdenum enzymes exhibit remarkable using 18O-labelled water have confirmed that the diversity of function and this is in part due to variations oxygen is incorporated into the product during at the Mo active site that are additional to the common substrate oxidation and this distinguishes the core structure. Prior to the appearance of X-ray crystal mononuclear molybdoenzymes from monoxygenases structures of molybdenum enzymes, EPR spectroscopy, where molecular oxygen rather than water acts as an X-ray absorption fine structure spectroscopy (EXAFS) oxygen atom donor (5). -
Data Driven Modelling of a Chemically Defined Growth Medium For
bioRxiv preprint doi: https://doi.org/10.1101/548891; this version posted February 13, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Data Driven Modelling of a Chemically Defined Growth Medium for Cupriavidus necator H16 Christopher C. Azubuike, Martin G. Edwards, Angharad M. R. Gatehouse and Thomas P. Howard School of Natural and Environmental Sciences, Faculty of Science, Agriculture and Engineering, Newcastle University, Newcastle-upon-Tyne, United Kingdom Cupriavidus necator is a Gram-negative soil bacterium of ma- as a chassis capable of exploiting renewable feedstock for jor biotechnological interest. It is a producer of the bioplas- the biosynthesis of valuable products (7). More widely, the tic 3-polyhydroxybutyrate, has been exploited in bioremedia- genus is known to encode genes facilitating metabolism of tion processes, and it’s lithoautotrophic capabilities suggest it environmental pollutants such as aromatics and heavy metals may function as a microbial cell factory upgrading renewable making it a potential microbial remediator (8, 9, 17–19). resources to fuels and chemicals. It remains necessary however to develop appropriate experimental resources to permit con- As with any bacterium, the development of C. necator as trolled bioengineering and system optimisation of this micro- an industrial chassis requires appropriate tools for studying bial chassis. A key resource for physiological, biochemical and and engineering the organism. One of these resources is metabolic studies of any microorganism is a chemically defined the availability of a characterised, chemically defined growth growth medium. -
Recent Progress in the Microbial Production of Pyruvic Acid
fermentation Review Recent Progress in the Microbial Production of Pyruvic Acid Neda Maleki 1 and Mark A. Eiteman 2,* 1 Department of Food Science, Engineering and Technology, University of Tehran, Karaj 31587-77871, Iran; [email protected] 2 School of Chemical, Materials and Biomedical Engineering, University of Georgia, Athens, GA 30602, USA * Correspondence: [email protected]; Tel.: +1-706-542-0833 Academic Editor: Gunnar Lidén Received: 10 January 2017; Accepted: 6 February 2017; Published: 13 February 2017 Abstract: Pyruvic acid (pyruvate) is a cellular metabolite found at the biochemical junction of glycolysis and the tricarboxylic acid cycle. Pyruvate is used in food, cosmetics, pharmaceutical and agricultural applications. Microbial production of pyruvate from either yeast or bacteria relies on restricting the natural catabolism of pyruvate, while also limiting the accumulation of the numerous potential by-products. In this review we describe research to improve pyruvate formation which has targeted both strain development and process development. Strain development requires an understanding of carbohydrate metabolism and the many competing enzymes which use pyruvate as a substrate, and it often combines classical mutation/isolation approaches with modern metabolic engineering strategies. Process development requires an understanding of operational modes and their differing effects on microbial growth and product formation. Keywords: auxotrophy; Candida glabrata; Escherichia coli; fed-batch; metabolic engineering; pyruvate; pyruvate dehydrogenase 1. Introduction Pyruvic acid (pyruvate at neutral pH) is a three carbon oxo-monocarboxylic acid, also known as 2-oxopropanoic acid, 2-ketopropionic acid or acetylformic acid. Pyruvate is biochemically located at the end of glycolysis and entry into the tricarboxylic acid (TCA) cycle (Figure1).